Skip to main navigation
VIR logo

SEC Filing Details

SEC Filing Details

Document Details

Form
8-K
Filing Date
Jul 14, 2022
Document Date
Jul 11, 2022
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Vir
Issuer
Vir Biotechnology, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
  • Corporate Governance
    • Charters & Governance
    • Leadership
  • Press Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • Investor Resources
    • FAQ
    • Investor Contact
    • Email Alerts
  • Financial Information
    • Quarterly Results
  • About
    • Mission
    • Leadership
  • Science
    • Platforms
    • Literature Archive
  • Pipeline
    • Our Focus
    • Our Collaborators
  • Careers
    • Join Us
    • VIRtues
    • Job Opportunities
  • Contact
  • Investors
    • Corporate Governance
      • Charters & Governance
      • Leadership
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Investor Resources
      • FAQ
      • Investor Contact
      • Email Alerts
    • Financial Information
      • Quarterly Results
  • Print Page
  • Email Alerts
  • RSS Feeds
  • Investor Contact
  • About
    • Mission
    • Leadership
  • Science
    • Platforms
    • Literature Archive
  • Pipeline
    • Our Focus
    • Our Collaborators
  • Careers
    • Join Us
    • VIRtues
    • Job Opportunities
  • Contact
  • Investors
    • Corporate Governance
      • Charters & Governance
      • Leadership
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • SEC Filings
    • Investor Resources
      • FAQ
      • Investor Contact
      • Email Alerts
    • Financial Information
      • Quarterly Results

vir logo white

Vir Biotechnology, Inc.
499 Illinois Suite 500
San Francisco, CA 94158
415-906-4324

email: info@vir.bio

  • LinkedIn
  • Twitter
©  Vir Biotechnology All rights reserved.
  • Privacy Policy
  • Terms of Use